Arsanis, Inc. (75) | Uncategorized (3)
- Option Agreement, dated March 18, 2021, by and between X4 Pharmaceuticals, Inc. and Abingworth Bioventures 8 LP (Filed With SEC on March 19, 2021)
- Description of Registered Securities (Filed With SEC on March 19, 2021)
- Description of Registered Securities (Filed With SEC on March 12, 2020)
